Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-07-01
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514469, 514622, A61K 31335, A61K 3134
Patent
active
056439431
ABSTRACT:
Methods for treating vascular inflammatory pathologies are disclosed. Particularly, the methods utilize pharmaceutical compositions containing certain compounds having an anti-inflammatory and anti-oxidant moiety covalently linked by an amide or ester bond. The compounds are useful in preventing and treating inflammatory disorders through several mechanisms.
REFERENCES:
Duniec, Z., et al.; "Antioxidant properties of some chemicals vs their influence on cyclooxygenase and lipoxidase activities", Biochemical Pharmacology, vol. 32, No. 14, pp. 2283-2286 (1983).
Bellavite, P.; "The Superoxide-Forming Enzymatic System of Phagocytes", Free Radical Biology & Medicine, vol. 4, pp. 225-261 (1988).
Duchstein, H., et al.; "Activated Species of Oxygen: A Challenge to Modern Pharmaceutical Chemistry", Archives of Pharmacology, vol. 325, pp. 129-146 (1992).
Sies, H., et al.; "Role of tocopherols in the protection of biological systems against oxidative damage", Journal of Photochemistry and Photobiology, vol. 8, pp. 211-224 (1991).
Chow, C.; "Vitamin E and Oxidative Stress", Free Radical Biology & Medicine, vol. II, pp. 215-232 (1991).
Petty, M., et al.; "Protective effects of an .alpha.-tocopherol analogue against myocardial reperfusion injury in rats", European Journal of Pharmacology, vol. 210, pp. 85-90 (1992).
Stampfer, M., et al.; "Vitamin E Consumption and the Risk of Coronary Disease in Women", New England Journal of Medicine, vol. 328, No. 20, pp. 1444-1449 (1993).
Steinberg, D., et al.; "Lipoprotein and Atherogenesis", JAMA, vol. 264, No. 3, pp. 3047-3052 (1990).
Rimm, E., et al.; "Vitamin E Consumption and the Risk of Coronary Heart Disease in Men", New England Journal of Medicine, vol. 328, No. 20, pp. 1450-1456 (1993).
PBJ Publications Ltd., Scrip, No. 1574, p. 31 (1990).
Carew, T., et al.; "Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lioprotein degradation in macrphage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit", Proceedings of the National Academy of Science, U.S.A., vol. 84, pp. 7725-7729 (1987).
Halliwell, et al.; "[1] Role of Free Radicals and Catalytic Metal Ions in Human Disease: An Overview", Methods in Enzymology, vol. 186, pp. 1-85 (1990).
Campbell, W.; "Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor", Goodman and Gilman's The Pharmacological Basis of Therapeutics, Pergman Press, NY, pp. 600-617 (1990).
Gifford, H.; "On the Treatment of Sympathetic Ophthalmia by Large Doses of Salicylate of Sodium, Aspirin, or Other Salicylic Compounds", Ophthalmoscope, vol. 8, pp. 257-259 (1910).
Vane, J., et al.; "Inflammation and the mechanism of action of anti-inflammatory drugs", FASEB Journal, vol. 1, pp. 89-96 (1987).
Rainsford, K. D. Inflammation and Mechanisms and Actions of Traditional Drugs, vol. I Anti-inflammatory and Anti-rheumatic drugs, Boca Raton, FL, CRC Press (1985).
Insel, P.; "Analgesic-Antipyretics and Antiinflammatory Agents: Drugs Employed in the Treatment of Rheumatoid Arthritis and Gout", Goodman and Gilman's The Pharmacological Basis of Therapeutics, pp. 638-669, 681 (1990).
Bonne, C., et al.; "2-(2-Hydroxy-4-methylphenyl)aminothiazole Hydrochloride as a Dual Inhibitor of Cyclooxygenase/Lipoxygenase and a Free Radical Scavenger", Drug Research, vol. 39(II), No. 10, pp. 1242-1250 (1989).
Nelson, P.; "Cyclooxygenase Inhibitors", CRC Handbook of Eicosanoids: Prostaglandins and Related Lipids, vol. II, Drugs Acting Via the Eicosanoids, CRC Press, Boca Raton, FL., pp. 59-133 (1989).
Cohen, N., et al.; "Lewis Acid Mediated Nucleophilic Substitution Reactions of 2-Alkoxy-3,4-dihydro-2H-1benzopyrans: Regiochemistry and Utility in the Synthesis of 3,4-Dihydro-2H-1-benzopyran-2-carboxylic Acids", Journal of Organic Chemistry, vol. 54, pp. 3282-3292 (1989).
Lamba, O., et al.; "Spectroscopic detection of lipid peroxidaiton products and structural changes ina sphingomyelin model system", Biochemica et Biophica Acta, vol. 1081, pp. 181-187 (1991).
Skoog, W., et al.; "Studies on the Fibrinogen, Dextran and Photohemagglutin in Methods of Isolating Leukocytes", Blood, vol. II, pp. 436-454 (1956).
Graff, G., et al.; "1-[4-[3-[4-[Bis(4-Fluorophenyl)Hydroxymethyl]-1-Piperidinyl]Propoxy]-3-Me thoxyphenyl]Ethanone(AHR-5333): A Selective Human Blood Neutrophil 5-Lipoxygenase Inhibitor", Prostaglandins, vol. 38, pp. 473-496 (1989).
Momsen, W., et al.; "Lipid Structural Reorganization Induced by the Pancreatic Lipase Cofactor, Procolipase", Biochemistry, vol. 34, pp. 7271-7281 (1995).
Smaby, J. M., et al; "Characterization of Lipid Miscibility in Liquid-Expanded Monolayers at the Gas-Liquid Interface", Langmuir, vol. 8, No. 2, pp. 563-570 (1992).
Bazan, H.; "Response of Inflammatory Lipid Mediators following Corneal Injury", Lipid Mediators in Eye Inflammation New Trends Lipid Mediators Res. Basel Karger vol. 5, pp. 1-11 (1990).
Goa, K., et al.; "Ocular Diclofenac", Drugs & Aging, vol. 2(6), pp. 473-486 (1992).
Gamache Daniel A.
Graff Gustav
Hellberg Mark R.
Nixon Jon C.
Alcon Laboratories Inc.
Gerstl Robert
Mayo Michael C.
LandOfFree
Systemic administration of esters and amides of antioxidants whi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systemic administration of esters and amides of antioxidants whi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systemic administration of esters and amides of antioxidants whi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597632